Written and reviewed by Meagan Williams, RN, BSN, CCRN

What GLP-1 weight loss actually costs, with every figure sourced.

Ask what semaglutide or tirzepatide costs and you will get answers ranging from about a hundred dollars a month to well over a thousand. Both are true, for different people, in different situations. This page explains what sits behind that spread, using prices the manufacturers publish themselves rather than numbers borrowed from a competitor's advert.

A pen, a folded pair of reading glasses and a printed page of figures on a pale stone table in soft daylight.

Key takeaways

  • Both manufacturers now publish cash prices directly. Novo Nordisk lists Wegovy self-pay at $349 per month for the pen at 0.25 mg through 2.4 mg (wegovy.com, checked August 2026), and Eli Lilly lists Zepbound single-dose vials at $299 to $449 per month depending on dose (zepbound.lilly.com, checked August 2026).
  • The dose changes the price. These medicines escalate over months, and both companies price by strength, so the first month is the cheapest month.
  • Insurance is the single biggest variable. In the KFF Health Tracking Poll released on 14 November 2025, 56% of GLP-1 users said the drugs were difficult to afford, including 55% of those with insurance.
  • Compounded versions are not FDA approved. They are often cheaper. That is a real trade-off and it should be discussed openly, not buried in a price list.
  • Medication price is not programme price. Consultation, monitoring and laboratory work are separate almost everywhere, including here.
  • This page is education, not medical advice. Whether a GLP-1 is appropriate for you is a clinical decision made with a prescriber.

How much does a GLP-1 weight loss medication cost per month?

Paying cash, the manufacturers' own published self-pay prices in August 2026 run from $149 per month for the oral form of Wegovy up to $699 per month for the highest doses of the Zepbound KwikPen at Eli Lilly's regular self-pay price. Most people paying cash for an injectable land between $299 and $449 per month. Those are medication prices only, and they do not include the consultation, the monitoring or any laboratory work.

That is a far narrower band than it was two years ago, and the reason is straightforward: in late 2025 both manufacturers cut their direct-to-consumer prices sharply. Novo Nordisk's news release of 17 November 2025 described lowering the self-pay price of Wegovy from $499 to $349 per month. Eli Lilly cut the price of Zepbound single-dose vials at the beginning of December 2025. Anyone quoting you a figure from 2024 is quoting a market that no longer exists.

What do Novo Nordisk and Eli Lilly actually charge if you pay cash?

Both companies publish their cash prices on their own patient websites, which makes them the most reliable figures available. The table below reproduces those published prices exactly as they stood when we checked them on 11 August 2026.

Manufacturer published self-pay prices, checked 11 August 2026
Product and dosePublished self-pay priceSource
Wegovy pen, 0.25 mg to 2.4 mg$349 per monthNovo Nordisk, wegovy.com
Wegovy HD pen, 7.2 mg$399 per monthNovo Nordisk, wegovy.com
Wegovy pen, first two months at 0.25 mg or 0.5 mg (introductory offer)$199 per monthNovo Nordisk, wegovy.com
Wegovy oral, 1.5 mg and 4 mg$149 per monthNovo Nordisk, wegovy.com
Zepbound single-dose vial, 2.5 mg$299 per monthEli Lilly, zepbound.lilly.com
Zepbound single-dose vial, 5 mg$399 per monthEli Lilly, zepbound.lilly.com
Zepbound single-dose vial, 7.5 mg to 15 mg$449 per monthEli Lilly, zepbound.lilly.com
Zepbound KwikPen, regular self-pay, 7.5 mg$499 per monthEli Lilly, zepbound.lilly.com
Zepbound KwikPen, regular self-pay, 10 mg to 15 mg$699 per monthEli Lilly, zepbound.lilly.com

Both programmes attach conditions. Novo Nordisk's introductory price applies only to the first two fills at the two lowest doses, and its oral pricing carries its own offer dates. Eli Lilly defines a one-month fill as 28 days, or four vials for the single-dose option, and its self-pay pricing runs through the Zepbound Self Pay Journey Program rather than through a pharmacy benefit. Read the programme terms on the manufacturer's own site before you rely on any of these figures.

Why we are quoting other companies' prices and not our own. WholeHealth Hydration does not publish its programme pricing, because the honest number depends on your dose, your medication, whether any of it is covered by your plan and how much clinical follow-up you need. What we can do is show you the sourced market figures, so you walk into any consultation, ours or anyone else's, knowing what the medication itself costs.

Why is the price of semaglutide and tirzepatide so different from one clinic to the next?

Four things move the number: whether you are using insurance or paying cash, which dose you are on, whether the product is the FDA-approved brand or a compounded version, and how much clinical care is bundled into the price. A quote that looks unusually low is usually excluding something, and the thing it excludes is most often the monitoring.

Those four variables compound. Two people can both be taking tirzepatide, in the same county, in the same month, and pay wildly different amounts, because one plan covers obesity medication and the other excludes it. Neither is being cheated. They are on different sides of a coverage line that has nothing to do with clinical need.

A registered nurse taking a seated client's blood pressure at a kitchen table during a routine check-in.
The follow-up visits are the part most often missing from a low advertised price.

Does insurance cover semaglutide or tirzepatide for weight loss?

Sometimes, and it depends entirely on the plan. Many plans cover these medicines for type 2 diabetes but exclude them for weight loss, and plans that do cover weight loss often require prior authorisation and documented criteria. In the KFF Health Tracking Poll released on 14 November 2025, 27% of insured GLP-1 users said they paid the full cost themselves, and 14% of users said they stopped taking the medication because of cost.

The same KFF poll found that 56% of everyone who had taken a GLP-1 said the drugs were difficult to afford, including 55% of those who had insurance. That second figure is the important one. Having coverage is not the same as the medicine being affordable, and a plan that covers the drug may still leave a substantial share with you.

The practical step is unglamorous but worth an afternoon: call the number on the back of your insurance card, ask specifically whether your plan covers GLP-1 medication for weight management as opposed to diabetes, and ask what the prior authorisation criteria are.

Why does the cost go up as the dose goes up?

Because these medicines are dosed by escalation, and both manufacturers price by strength. On Eli Lilly's published self-pay pricing for the Zepbound single-dose vial, a one-month fill is $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg upward. The practical lesson is to budget for the maintenance dose rather than the starting dose, because the starting dose is the cheapest month you will have.

This is the most common budgeting mistake we see. Somebody prices the programme on the starting dose, commits, then finds a few months later that the monthly figure has moved. Escalation is deliberate and slow, because escalating quickly is what makes people feel unwell. It is a clinical decision with a cost consequence you should see coming.

Novo Nordisk prices Wegovy differently, holding a single self-pay figure across doses 0.25 mg through 2.4 mg. If predictability matters more to you than the lowest possible starting figure, that flat structure is worth weighing. We compare how the two medicines differ clinically on our semaglutide versus tirzepatide page.

Is compounded semaglutide cheaper than the brand?

It is often advertised at a lower monthly price, but compounded semaglutide and tirzepatide are not FDA approved. The FDA's position is that compounded drugs do not go through its premarket review for safety, effectiveness or quality, and that they therefore carry more risk than FDA-approved products. The FDA has also proposed excluding semaglutide, tirzepatide and liraglutide from the list of bulk substances that outsourcing facilities may compound from. That is a decision to make with a prescriber, with the regulatory status openly on the table.

Read this before comparing a compounded price A lower advertised price for a compounded product is not the same product at a discount. It is a different product with a different regulatory status. The FDA has issued warning letters to sellers whose marketing implied compounded GLP-1 products had been reviewed for safety and effectiveness when they had not. If a website tells you its compounded semaglutide is FDA approved, that statement is false, and it tells you something about the seller.

None of that means every compounded product is dangerous, or that no prescriber should ever consider one. It means the price difference is not free, and anybody quoting a compounded price without mentioning any of this is leaving out the part that matters.

What is usually left out of an advertised GLP-1 price?

Commonly: the initial consultation, follow-up visits, laboratory work, the price change at each dose increase, and any charge for switching medicines if the first one does not suit you. Ask whether the advertised figure is the medication alone or the whole programme, and ask what the monthly figure becomes at a maintenance dose rather than at the starting dose.

One more omission is worth naming, because it is the expensive one. A programme priced purely on shipping a medication has no line item for the visit where somebody notices that your blood pressure has drifted, that a fortnight of poor intake has left you dehydrated, or that what you are calling ordinary nausea is not ordinary. A price that does not include those visits is not cheaper. It is smaller.

Three Real Situations

The same medicine, three very different bills.

Covered by a plan

Your plan covers GLP-1 medication for weight management and prior authorisation is approved. You pay a co-pay, and the manufacturers' cash prices are irrelevant to you. This is the cheapest route by a wide margin when it is available.

Paying cash for the brand

Your plan excludes weight management, so you buy directly. Novo Nordisk publishes $349 per month for the Wegovy pen at 0.25 mg to 2.4 mg, and Eli Lilly publishes $299 to $449 per month for Zepbound single-dose vials by dose. Clinical care sits on top.

Chasing the lowest number

A compounded product from an online seller quotes less than any figure above. It is not the same product, it is not FDA approved, and the price rarely includes anybody looking at you. Sometimes reasonable. Never automatic.

Before You Pay Anyone

What should you ask before you pay for anything?

Six questions. Ask all of them, of us and of anybody else, and the real cost stops being a mystery.

1. Is this figure the medication only, or the whole programme?
2. What does the monthly figure become at a maintenance dose?
3. Is this the FDA-approved brand or a compounded product?
4. How many follow-up visits are included, and what happens after those?
5. What am I charged if I need to switch medicines or stop?
6. Have you checked whether my plan would cover this first?

Question six is the one most sellers skip, because the honest answer sometimes costs them the sale. It is also the question most likely to save you the most money.

Does WholeHealth Hydration bill insurance or Medicare for weight loss care?

No. WholeHealth Hydration is a private-pay practice. It is not a Medicare-certified provider and it does not bill Medicare or health insurance for weight loss care. Any pharmacy benefit you hold for the medication itself sits between you, your prescriber and your plan, and we will tell you plainly when using that benefit is the cheaper route.

That is not a limitation we hide. If a covered pharmacy benefit makes your medication cost a fraction of what the cash programmes charge, we want you to know before you spend anything with us.

Where WholeHealth Hydration fits

Meagan Williams is a Registered Nurse with critical-care certification, and she coordinates and supervises care delivered by vetted RN and LVN staff under her clinical oversight. What that buys is the part of a weight loss programme a shipping label cannot provide: somebody qualified in the room, noticing changes early.

If you want the clinical picture rather than the financial one, our medical weight loss page explains how the programme works and who it suits, and our GLP-1 side effects page publishes the full adverse reaction list with the placebo comparison rates straight from the FDA label.

This page is education, not medical advice Semaglutide and tirzepatide are prescription medicines. Whether either is appropriate for you is a clinical decision made with a prescriber who knows your history. Nothing here should be read as a recommendation to start, stop or change a medication, and nothing here is a quotation or an offer of price.

Sources, and when these figures were checked

  • Novo Nordisk, Wegovy coverage and savings information (wegovy.com and novocare.com), for the $349, $399, $199 and $149 per month self-pay figures. Checked 11 August 2026.
  • Novo Nordisk news release, 17 November 2025, for the reduction of the Wegovy self-pay price from $499 to $349 per month.
  • Eli Lilly and Company, Zepbound coverage and savings information (zepbound.lilly.com), for the $299, $399, $449, $499 and $699 per month self-pay figures and the Self Pay Journey Program terms. Checked 11 August 2026.
  • KFF Health Tracking Poll, released 14 November 2025, for the 56%, 55%, 27% and 14% affordability figures.
  • U.S. Food and Drug Administration, published guidance and statements on compounded GLP-1 drug products, for the regulatory status of compounded semaglutide and tirzepatide.

Prices in this category have moved several times in the past year and will move again. Every figure on this page was checked in August 2026. Confirm current pricing directly with the manufacturer or your pharmacy before making a decision based on any of it.

Start With A Conversation

Get the honest number for your situation.

A consultation is a conversation, not a sales call. If your insurance would cover this more cheaply, or if you are not a candidate at all, you will hear it from us first.

Common Questions

GLP-1 cost, answered.

How much does a GLP-1 weight loss medication cost per month?

Paying cash, the manufacturers' own published self-pay prices in August 2026 run from $149 per month for the oral form of Wegovy up to $699 per month for the highest doses of the Zepbound KwikPen at Eli Lilly's regular self-pay price. Most people paying cash for an injectable land between $299 and $449 per month. Those are medication prices only, and they do not include the consultation, the monitoring or any laboratory work.

Why is the price of semaglutide and tirzepatide so different from one clinic to the next?

Four things move the number: whether you are using insurance or paying cash, which dose you are on, whether the product is the FDA-approved brand or a compounded version, and how much clinical care is bundled into the price. A quote that looks unusually low is usually excluding something, and the thing it excludes is most often the monitoring.

Does insurance cover semaglutide or tirzepatide for weight loss?

Sometimes, and it depends entirely on the plan. Many plans cover these medicines for type 2 diabetes but exclude them for weight loss, and plans that do cover weight loss often require prior authorisation and documented criteria. In the KFF Health Tracking Poll released on 14 November 2025, 27% of insured GLP-1 users said they paid the full cost themselves, and 14% of users said they stopped taking the medication because of cost.

Why does the cost go up as the dose goes up?

Because these medicines are dosed by escalation, and both manufacturers price by strength. On Eli Lilly's published self-pay pricing for the Zepbound single-dose vial, a one-month fill is $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg upward. The practical lesson is to budget for the maintenance dose rather than the starting dose, because the starting dose is the cheapest month you will have.

Is compounded semaglutide cheaper than the brand?

It is often advertised at a lower monthly price, but compounded semaglutide and tirzepatide are not FDA approved. The FDA's position is that compounded drugs do not go through its premarket review for safety, effectiveness or quality, and that they therefore carry more risk than FDA-approved products. The FDA has also proposed excluding semaglutide, tirzepatide and liraglutide from the list of bulk substances that outsourcing facilities may compound from. That is a decision to make with a prescriber, with the regulatory status openly on the table.

What is usually left out of an advertised GLP-1 price?

Commonly: the initial consultation, follow-up visits, laboratory work, the price change at each dose increase, and any charge for switching medicines if the first one does not suit you. Ask whether the advertised figure is the medication alone or the whole programme, and ask what the monthly figure becomes at a maintenance dose rather than at the starting dose.

Does WholeHealth Hydration bill insurance or Medicare for weight loss care?

No. WholeHealth Hydration is a private-pay practice. It is not a Medicare-certified provider and it does not bill Medicare or health insurance for weight loss care. Any pharmacy benefit you hold for the medication itself sits between you, your prescriber and your plan, and we will tell you plainly when using that benefit is the cheaper route.

Book a Consultation Call